Erythropoientin mimetic peptides and the future

Nephrology Dialysis Transplantation

Volumn 15, Issue 9, 2000, Pages 1274-1277

  Johnson, Dana L ^a   Jolliffe, Linda K ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INSULIN RECEPTOR; PEPTIDE DERIVATIVE; RECOMBINANT ERYTHROPOIETIN; THROMBOPOIETIN; PEPTIDE;

AGONIST; ANEMIA; BINDING SITE; CHRONIC KIDNEY FAILURE; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; EDITORIAL; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; FORECASTING; MOLECULAR MIMICRY; PHYSIOLOGY;

ERYTHROPOIETIN; FORECASTING; HUMANS; MOLECULAR MIMICRY; PEPTIDES;

EID: 0034268332     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.9.1274     Document Type: Editorial

References (27)

1. Erythropoietin
2. Erythropoietin: Physiologic and pharmacologic aspects
3. Erythropoietin receptor: Application in drug development
4. New epoetin molecules and novel therapeutic approaches
5. The structure, organization, activation and plasticity of the erythropoietin receptor
6. Haematopoietin sub-family classification based on size, gene organization and sequence homology
7. Structural design and molecular evaluation of a cytokine receptor superfamily
8. Jak-STAT pathways and transcriptional activation in response to IFNa and other extracellular signaling proteins
9. A hot spot of binding energy in a hormone-receptor interface
10. Binding in the growth hormone receptor complex
11. Small peptides as potent mimetics of the protein hormone erythropoietin
12. Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 Å
13. Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMPI
14. Increased potency of an erythropoietin peptide mimetic through covalent dimerization
15. Amino terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity
16. Isolation of Erythropoietin Receptor Agonist Peptides Using Evolved Phage Libraries
17. Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site
18. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine
19. Design principles for orally bioavailable drugs
20. Mimicry of erythropoietin by a nonpeptide molecule
21. Discovery of a small molecule with anti-diabetic activity in mice
22. A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor
23. EPO mimetic peptide fused into PAI-1 augments its EPO activity
24. Efficiency of signaling through cytokine receptors depends critically on receptor orientation
25. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation
26. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
27. Erythropoietin receptor activation by a ligand-induced conformation change